Lilly, insulin users end $13.5M settlement plan following federal judge's decision
A settlement between Eli Lilly and insulin users has collapsed after a federal judge’s ruling that denied class certification for the lawsuit.
The original settlement …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.